CAS: 57-94-3; (+)-Tubocurarine Chloride,2,3,13A,14,15,16,25,25A,-Octahydro-9,19-Dihydroxy-18,29-Dimethoxy-1,14,14-Trimethyl-13H-4,6:21,24-Dietheno-8,12-Metheno-1H-Pyrido[3',2':14,15][1,11]Dioxacycloeicosino[2,3,4-Ij]Isoquinoliniumchloridehydrochloride

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号7601-55-0 二甲基四碘

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9315483-B2
    优先权日:2007-09-13
    标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
    发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
    权利人:CONCERT PHARMACEUTICALS INC
    摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

    专利号:WO-0112817-A1
    优先权日:1999-08-12
    标题:Evolution and use of enzymes for combinathorial and medicinal chemistry
    发明人:KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
    权利人:MAXYGEN INC; LIU LU; KREBBER CLAUS; DAVIS S CHRISTOPHER; DELCARDAYRE STEPHEN; SELIFONOV SERGEY A; HOWARD RUSSELL
    摘要:This invention provides libraries of recombinant derivatizing enzymes that are useful for biocatalytic synthesis of derivatives oforganic molecules, including lead compounds for pharmaceutical use. The recombinant derivatizing enzymes catalyze reactions such as modification or replacement of functional groups on the organicmolecules, or addition of chemical moieties onto preexisting functional groups. The use of recombinant enzyme libraries enables one to obtain enzymes that catalyze the formation of organic molecule derivatives that could not otherwise be made using only naturally occurring enzymes.

    专利号:US-7579461-B2
    优先权日:2004-01-15
    标题:Processes for the preparation of rocuronium bromide and intermediates thereof
    发明人:ADAR ELIEZER; SONDACK DAVID; FRIEDMAN ODED; MANASCU IOSEF; FIZITZKI TAMIR; FREGER BORIS; ARAD ODED; WEISMAN ALEXANDER; KASPI JOSEPH
    权利人:CHEMAGIS LTD
    摘要:A novel process for preparing (2β,3α,5α,16β,17β)-17-acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl) androstane, a known intermediate in the synthesis of the skeletal muscle relaxant rocuronium bromide, is disclosed.

    专利号:WO-9925385-A1
    优先权日:1997-11-17
    标 题:A method of increasing nucleic acid synthesis with ultrasound
    发明人:UNGER EVAN C; MCCREERY THOMAS; SADEWASSER DAVID
    权利人:IMARX PHARMACEUTICAL CORP
    摘要:The present invention is directed to a method of increasing nucleic acid synthesis in a cell comprising administering to the cell a therapeutically effective amount of ultrasound for a therapeutically effective time such that said administration of said ultrasound results in said increased nucleic acid synthesis. The nucleic acid sequence may comprise an endogenous sequence or an exogenous sequence.

    专利号:WO-2009035652-A1
    优先权日:2007-09-13
    标 题 :Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof

    专利号:US-6800663-B2
    优先权日:2002-10-18
    标 题:Crosslinked hydrogel copolymers
    发明人:ASGARZADEH FIROUZ; COSTANTINO HENRY R
    权利人:ALKERMES INC
    摘要:The present invention relates to crosslinked polymers, synthesized through ring-opening polymerization of ethylenically unsaturated epoxides, in combination with α-hydroxy acids using a hydrophilic macroinitiator, such as poly(ethylene glycol), to form substituted copolymers having ethylenically unsaturated functionality randomly distributed along the polyester polymer backbone. That copolymer is subsequently crosslinked to form a hydrogel network. More particularly, the present invention relates to the synthesis of biodegradable poly(α-hydroxy acid-co-glycidyl methacrylate)-block-poly(ethylene glycol)-block-poly(α-hydroxy acid-co-glycidyl methacrylate) copolymers, which are subsequently crosslinked to form hydrogel networks. The invention also relates to the use of these hydrogel networks in various applications, in particular, for the controlled release of drugs and proteins.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Chen X, Li Y, Hollenberg M, Triggle CR, Ding H. The contribution of d-tubocurarine-sensitive and apamin-sensitive K-channels to EDHF-mediated relaxation of mesenteric arteries from eNOS-/- mice. J Cardiovasc Pharmacol. 2012 May;59(5):413-25. doi: 10.1097/FJC.0b013e318248acd9. doi: 10.1093/bja/aer117. Epub 2011 May 24. doi: 10.1371/journal.pbio.1001034. Epub 2011 Mar 29.
    4: Su TR, Hung YS, Huang SS, Su HH, Su CC, Hsiao G, Chen YH, Lin MJ. Study of the reversal effect of NF449 on neuromuscular blockade induced by d-tubocurarine. Life Sci. 2011 Jun 6;88(23-24):1039-46. doi: 10.1016/j.lfs.2011.03.013. Epub 2011 Mar 28. doi: 10.1007/s00540-009-0816-6. Epub 2009 Nov 18. doi: 10.1097/ALN.0b013e31819faeaa. doi: 10.2478/v10042-008-0016-5. Epub 2006 May 24. Epub 2006 Jan 3. Epub 2004 Jul 26.
    15: Suzuki T, Munakata K, Watanabe N, Fukano N, Saeki S, Ogawa S. Comparative fading responses induced by mivacurium, cisatracurium, and d-tubocurarine in the evoked muscular compound action potentials of the cat. J Anesth. 2003;17(2):98-103. Epub 2002 Aug 23.

    合成参考文献


    摘要:Russian Pharmacology and Toxicology, 32(74), 1969
    摘要:Proceedings of the Society for Experimental Biology and Medicine., 120(511), 1965 []
    摘要:Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU., 24(12)(24), 1990
    摘要:Oyo Yakuri. Pharmacometrics., 9(117), 1975
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知